Sunscreen monograph amendment
This article was originally published in The Tan Sheet
Labeling of sunscreen products introduced after Sept. 1 will need to reflect USP name changes for four active ingredients, FDA says in technical amendment published in Federal Register June 20. Changes were proposed by USP in 2000 based on designations approved by U.S. Adopted Names Council. Proposal was accepted in March 2001, becomes effective Sept. 1. New names include meradimate for menthyl anthranilate; octinoxate for octyl methoxycinnamate; octisalate for octyl salicylate; and ensulizole for phenylbenzimidazole sulfonic acid. Comments on amendment will be accepted until Aug. 19...
You may also be interested in...
FDA will not take enforcement action against sunscreen manufacturers unable to re-label products to reflect required name changes for four ingredients before Sept. 1, the agency said in guidance to industry
A Sept. 1 deadline for amending the names of four sunscreen ingredients on labeling would "unnecessarily disrupt the supply of sunscreen products," the Consumer Healthcare Products Association and Cosmetic, Toiletry & Fragrance Association tell FDA
The independent, family-controlled German group has signed a third R&D pact with Danish biotech Gubra to develop poly-agonist peptides for obesity.